BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25644707)

  • 1. Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency.
    de Andrea CE; Zhu JF; Jin H; Bovée JV; Jones KB
    J Pathol; 2015 Jun; 236(2):210-8. PubMed ID: 25644707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
    de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
    Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas.
    Musso N; Caronia FP; Castorina S; Lo Monte AI; Barresi V; Condorelli DF
    Cancer Genet; 2015 Mar; 208(3):62-7. PubMed ID: 25744876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
    Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
    Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.
    Bovée JV; Cleton-Jansen AM; Wuyts W; Caethoven G; Taminiau AH; Bakker E; Van Hul W; Cornelisse CJ; Hogendoorn PC
    Am J Hum Genet; 1999 Sep; 65(3):689-98. PubMed ID: 10441575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
    Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
    Jones KB; Piombo V; Searby C; Kurriger G; Yang B; Grabellus F; Roughley PJ; Morcuende JA; Buckwalter JA; Capecchi MR; Vortkamp A; Sheffield VC
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2054-9. PubMed ID: 20080592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
    Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T
    Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma.
    de Andrea CE; Wiweger M; Prins F; Bovée JV; Romeo S; Hogendoorn PC
    Lab Invest; 2010 Jul; 90(7):1091-101. PubMed ID: 20421870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses.
    Bovée JV; Sakkers RJ; Geirnaerdt MJ; Taminiau AH; Hogendoorn PC
    J Clin Pathol; 2002 Mar; 55(3):226-9. PubMed ID: 11896078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
    Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
    Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.
    Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M
    J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter.
    de Andrea CE; Hogendoorn PC
    J Pathol; 2012 Jan; 226(2):219-28. PubMed ID: 21956842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.
    Matsumoto K; Irie F; Mackem S; Yamaguchi Y
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10932-7. PubMed ID: 20534475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
    Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
    Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas.
    Kyriazoglou AI; Dimitriadis E; Arnogiannaki N; Brandal P; Heim S; Pandis N
    Cancer Genet; 2011 Dec; 204(12):677-81. PubMed ID: 22285020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
    Hameetman L; Szuhai K; Yavas A; Knijnenburg J; van Duin M; van Dekken H; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    J Natl Cancer Inst; 2007 Mar; 99(5):396-406. PubMed ID: 17341731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteochondromas: review of the clinical, radiological and pathological features.
    Kitsoulis P; Galani V; Stefanaki K; Paraskevas G; Karatzias G; Agnantis NJ; Bai M
    In Vivo; 2008; 22(5):633-46. PubMed ID: 18853760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
    van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of hedgehogs and hereditary bone tumors: re-examination of the pathogenesis of osteochondromas.
    Jones KB; Morcuende JA
    Iowa Orthop J; 2003; 23():87-95. PubMed ID: 14575257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.